FDA recalls Oxytocin product for low potency nationwide
SCA Pharmaceuticals is recalling Oxytocin 30 units in 0.9% Sodium Chloride solution (73,312 containers) nationwide due to subpotency—product contains insufficient active ingredient.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III recall for a product defect with no reported illnesses or injuries. Per rubric guidelines, Class III recalls are typically scored 1-2, and this subpotency issue presents theoretical rather than documented harm.
Plain-English summary
SCA Pharmaceuticals is recalling Oxytocin 30 units added to 0.9% Sodium Chloride 500 mL (NDC 70004-085-44) due to subpotency. FDA testing determined the product does not meet potency specifications. The recall affects 73,312 single-dose containers distributed nationwide. Affected lot numbers range from 1222043028 through 1223044868, manufactured between April 11, 2023, and July 8, 2023.
No illnesses or injuries have been reported. However, subpotent medication may not produce the intended therapeutic effect, which is particularly significant for a prescription oxytocic used in time-sensitive clinical settings. Healthcare providers should discontinue use of affected lots and contact their supplier or the manufacturer for replacement product.
The recalled product
- Product
- Oxytocin 30 units added to 0.9% Sodium Chloride 500 mL, Rx Only, Single Dose Container, SCA Pharmaceuticals, Windsor, CT 06095, NDC# 70004-085-44
- Manufacturer
- SCA Pharmaceuticals
- Category
- Drug — Injectable
- Hazard
- subpotency
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01